Published in Surgery Litigation and Law Weekly, January 12th, 2007
Fiscal 2006 revenue was $859 million, 6% above fiscal 2005, 8% in constant currency.
The company reported EPS 30 cents for the fourth quarter, $1.44 for fiscal 2006. These results include share-based compensation costs, acquisition and restructuring expenses, intellectual property and securities litigation costs and foreign exchange gains/losses totaling $17.6 million net of tax, or 37 cents per diluted share for the quarter and $61.2...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Surgery Litigation and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.